Abstract
Objective
To assess the utility of 24 and 48 hours transcutaneous bilirubin (TcB) index for predicting subsequent significant hyperbilirubinemia in healthy term neonates.
Methods
TcB indices were obtained for healthy, breastfed, term AGA newborns at 24 ± 2, 48 ± 2 and subsequently at intervals of 24 hours. Neonates with illness, on treatment and positive Direct Coomb’s test were excluded. Serum bilirubin levels were obtained whenever indicated. Neonates having serum bilirubin ≥ 17 mg/dL were considered as significant hyperbilirubinemia. The 24 and 48 hour TcB indices, as risk predictors for such hyperbilirubinemia were determined.
Results
Study included 461 healthy term neonates. The mean birth weight was 2949 (± 390) gm and mean gestation of 38.6 (± 1.1) weeks. Eight one (17.6%) had significant hyperbilirubinemia. Of 461, 135 (29.3%) had TcB index < 5 at 24 hours and 200 (43.3%) had index < 8 at 48 hours. None of them had later hyperbilirubinemia (100 % negative predictive value). Significant hyperbilirubinemia increased from 8.1 % to 76.4% as 24 hours TcB index raised from 5 to 9 and from 10.4 % to 83.7% as 48 hour TcB index raised from 8 to 11. Sensitivity and specificity were optimised at TcB value of 7(risk: OR=26.8, 95%Cl: 13.9–51.5) at 24 hours and 10 (risk: OR= 17.1, 95%Cl 8.9–32.9) at 48 hours. C-statistics for 24 and 48 hour measurements are 0.838 and 0.836 respectively.
Conclusion
The 24 and 48 hour TcB indices are predictive for subsequent significant hyperbilirubinemia and can guide clinician in early discharge of healthy term newborns.
Similar content being viewed by others
References
Johnson L, Bhutani VK. Guidelines for management of the jaundiced term and near term infant. Clin Perinatol 1998; 25: 555–574.
Bhutani VK, Johnson LH, Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin N Am 2004; 51: 843–861.
Johnson L, Brown AK, Bhutani VK. System based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002; 93: 488–494.
Bhutani VK, Johnson L, Sivieri EM. Predictive ability of predischarge hour specific serum bilirubin for subsequent significant hyperbilirubinemia in a healthy term and near term newborns. Pediatrics 1999; 104: 6–14.
Bhutani VK. For a safer outcome with newborn jaundice. Indian Pediatr 2004; 41: 321–325.
Friedman MA, Spitzer AR. Discharge criteria for the term newborn. Pediatr Clin N Am 2004; 51: 599–618.
Bhutani VK, Gourley GR, Adler S et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000; 106. Available at: http://pediatrics.org/cgi/content/full/106/2/e17
Maisels MJ, Kring EA. Length of stay, jaundice and hospital readmission. Pediatrics 1998; 101: 995–998.
Maisels MJ, Newman TB. Jaundice in full term and near-term babies who leave the hospital within 36 hours. The pediatrician’s nemesis. Clin Perinatol 1998; 25: 295–302.
Stevenson DK, Fanaroff AA, Maisels MJ et al. Prediction of hyperbilirubinemia in near term and term infants. Pediatrics 2001; 108: 31–39
Carbonell X, Botet F, Figueras J, Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr 2001; 90: 166–170.
Rosenfeld J. Umbilical cord bilirubin levels as a predictor of subsequent hyperbilirubinemia. J Fam Pract 1986; 23: 556–558 (Medline).
Jacobson MP, Bernstein HH. Limited value of routine cord blood bilirubin determinations. Clin Pediatr 1982; 21: 610–612.
Gelinas H, Guay M, Leclerc P. Transcutaneous bilirubinometry in the context of early postnatal discharge. (CETS 99-6RA). Montreal: CETS; 2000:xvi–50p. Available at http://www.cets.gouv.qc.ca
Engle WD, Jackson GL, Sendelbach D, Manning D, Frawley W. Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. Pediatrics 2002; 110: 61–67.
Hegyi T, Hiatt IM, Indyk L. Transcutaneous bilirubinometry: Correlations in term infants. J Pediatr 1981; 98: 454–457.
Yamauchi Y. Transcutaneous bilirubinometry. Evaluation of accuracy and reliability in a large population. Acta Paediatr Scand 1988; 77: 791–795.
Janjindamai W, Tansantiwong T. Accuracy of transcutaneous bilirubinometer estimates using BiliCheck in Thai neonates. J Med Assoc Thai 2005; 88: 187–190.
Nanjundaswamy S, Petrova A, Mehta R et al. The accuracy of transcutaneous bilirubin measurements in neonates: a correlation study. Biol Neonate 2004; 85: 21–25.
Ho EY, Lee SY, Chow CB, Chung JW. BiliCheck transcutaneous bilirubinometer: a screening tool for neonatal jaundice in the Chinese population. Hong Kong Med J 2006; 12: 99–102.
Slushier TM, Anglo IA, Bode-Thomas F, Transcutaneous bilirubin measurements and serum total bilirubin levels in indigenous African infants. Pediatrics 2004; 113: 1636–1641.
Faridi MMA, Gupta D. Non-Invasive Estimation of total serum bilirubin. Indian Pediatr 2000; 37: 1404–1407.
Harish R, Sharma DB. Transcutaneous bilirubinometry in neonates: Evaluation of Minolta Air Shields Jaundice Meter. Indian Pediatr 1998; 35: 264–267.
Lodha R, Deorari AK, Jatana V, Paul VK. Non-invasive estimation on total serum bilirubin by multi length spectral reflectance in neonates. Indian Pediatr 2000; 37: 771–775.
Gagan M, Kaushal RK, Naveen S et al. Trancutaneous bilirubinometry in assessment of neonatal jaundice in Northern India. Indian Pediatr 2005; 42: 41–45.
Briscoe L, Clark S, Yoxall C. Can transcutaneous bilirubinometry reduce the need for blood tests in jaundiced full term babies? Arch Dis Child Fetal Neonatal Ed 2002; 86: F190–F192.
Alpay F, Sarici SU, Tosuncuk HD et al. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics 2006;106:E16 Available at: pediatrics.org/cgi/content/full/106/2/e16
Saricik SU, Yurdakok M, Serdar MA et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics 2002; 109: e53
Grohmann K, Roser M, Rolinski B et al. Bilirubin Measurement for Neonates: Comparison of 9 Frequently Used Methods. Pediatrics 2006; 117: 1174–1183.
Felc Z. Improvement of conventional transcutaneous bilirubinometry results in term newborn infants. Am J Perinatol 2005; 22: 173–179.
Yasuda S, Itoh S, Isobe K et al. New transcutaneous jaundice device with two optical paths. J Perinat Med 2003; 31: 81–88.
Rubaltelli FF, Gourley GR, Loskamp N et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics 2001; 107: 1264–1271.
Wong CM, van Dijk PJE, Laing IA. A comparison of transcutaneous bilirubinometers: Spectrx Bilicheck versus Minolta Airshields. Arch Dis Child Fetal Neonatal Ed 2002; 87: F137–F140.
Ebbesen F, Rasmussen LM, Wimberley PD. A new transcutaneous bilirubinometer, Bilicheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr 2002; 91: 203–211.
Maisels JM, Ostrea EM, Suzanne T et al. Evaluation of a New Transcutaneous Bilirubinometer. Pediatrics 2004; 113: 1628–1635.
Maisels M. J. Use of TcB as a screening tool for jaundiced newborns. AAP News 2004; 25: 9–13.
Eggert LD, Wiedmeier SE, Wilson J et al. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system Pediatrics 2006; 117: e855–e862.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhat, Y.R., Rao, A. Transcutaneous bilirubin in predicting hyperbilirubinemia in term neonates. Indian J Pediatr 75, 119–123 (2008). https://doi.org/10.1007/s12098-008-0017-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-008-0017-6